50mg Per Capsule Oral Administration NNMT Target Enzyme 22+ BHRC Locations Available Option An oral NNMT inhibitor designed to support cellular energy metabolism and metabolic function through targeted enzyme modulation
The clearest guidance comes from injection science more broadly
For example, if a patient gets 1000 mcg in 1 mL of 1000 mcg/mL solution, changing to 500 mcg/mL means you need 2 mL to get the same dose
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
They can provide recommendations on how to achieve a moderate weight in a healthy, sustainable manner
This response affects some patients and can manifest in various ways, from fatigue to physical discomfort